Swedish Biotech Breakthroughs

Xbrane Biopharma

Market Cap: SEK 670.1m

A biotechnology company, engages in the development, manufacture, and sale of biosimilars.

Guard Therapeutics International

Market Cap: SEK 459.8m

A pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden.

Xspray Pharma

Market Cap: SEK 1.8b

A pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden.

Lipigon Pharmaceuticals

Market Cap: SEK 104.5m

Develops drugs for lipid related diseases in Sweden.

Devyser Diagnostics

Market Cap: SEK 2.5b

Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.

BioInvent International

Market Cap: SEK 1.9b

A clinical-stage company, discovers and develops immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally.

Diamyd Medical

Market Cap: SEK 1.7b

Develops precision medicine therapies for the treatment of autoimmune diabetes.

SynAct Pharma

Market Cap: SEK 1.0b

A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.

Active Biotech

Market Cap: SEK 204.2m

A biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden.

Mendus

Market Cap: SEK 364.6m

A biopharmaceutical company, develops immunotherapies for the treatment of tumor recurrence and established tumors.